These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 31244652)

  • 1. Drugs Targeting Epigenetic Modifications and Plausible Therapeutic Strategies Against Colorectal Cancer.
    Patnaik S; Anupriya
    Front Pharmacol; 2019; 10():588. PubMed ID: 31244652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA methylation of CMTM3, SSTR2, and MDFI genes in colorectal cancer.
    Li J; Chen C; Bi X; Zhou C; Huang T; Ni C; Yang P; Chen S; Ye M; Duan S
    Gene; 2017 Sep; 630():1-7. PubMed ID: 28782576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of epigenetic modifications in Colorectal Cancer Metastasis.
    Su R; Wu X; Tao L; Wang C
    Clin Exp Metastasis; 2022 Aug; 39(4):521-539. PubMed ID: 35429301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring Potential Epigenetic Biomarkers for Colorectal Cancer Metastasis.
    Ajithkumar P; Vasantharajan SS; Pattison S; McCall JL; Rodger EJ; Chatterjee A
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of epigenetic therapies in colorectal cancer.
    Baretti M; Azad NS
    Curr Probl Cancer; 2018 Nov; 42(6):530-547. PubMed ID: 29625794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetics and its therapeutic potential in colorectal cancer.
    Oryani MA; Tavasoli A; Ghalavand MA; Ashtiani RZ; Rezaee A; Mahmoudi R; Golvari H; Owrangi S; Soleymani-Goloujeh M
    Epigenomics; 2022 Jun; 14(11):683-697. PubMed ID: 35473313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unveiling the genetic and epigenetic landscape of colorectal cancer: new insights into pathogenic pathways.
    Postwala H; Shah Y; Parekh PS; Chorawala MR
    Med Oncol; 2023 Oct; 40(11):334. PubMed ID: 37855910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic profiling of MUTYH, KLF6, WNT1 and KLF4 genes in carcinogenesis and tumorigenesis of colorectal cancer.
    Babaei K; Khaksar R; Zeinali T; Hemmati H; Bandegi A; Samidoust P; Ashoobi MT; Hashemian H; Delpasand K; Talebinasab F; Naebi H; Mirpour SH; Keymoradzadeh A; Norollahi SE
    Biomedicine (Taipei); 2019 Dec; 9(4):22. PubMed ID: 31724937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylated
    Li J; Zhou C; Ni S; Wang S; Ni C; Yang P; Ye M
    Oncotarget; 2017 Nov; 8(56):96249-96262. PubMed ID: 29221203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic Drug Therapy in the Treatment of Colorectal Cancer.
    Parizadeh SM; Jafarzadeh-Esfehani R; Ghandehari M; Seifi S; Parizadeh SMR; Moetamani-Ahmadi M; Hassanian SM; Khazaei M; Ghayour-Mobarhan M; Ferns GA; Avan A
    Curr Pharm Des; 2018; 24(23):2701-2709. PubMed ID: 30062956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiota and epigenetics in colorectal cancer: implications for carcinogenesis and therapeutic intervention.
    Pandey M; Bhattacharyya J
    Epigenomics; 2024 Mar; 16(6):403-418. PubMed ID: 38410915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic silencing of tumor suppressor candidate 3 confers adverse prognosis in early colorectal cancer.
    Burgermeister E; Höde P; Betge J; Gutting T; Merkel A; Wu W; Tänzer M; Mossner M; Nowak D; Magdeburg J; Rückert F; Sticht C; Breitkopf-Heinlein K; Schulte N; Härtel N; Belle S; Post S; Gaiser T; Heppner BI; Behrens HM; Röcken C; Ebert MPA
    Oncotarget; 2017 Oct; 8(49):84714-84728. PubMed ID: 29156678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic-based therapy for colorectal cancer: Prospect and involved mechanisms.
    Rezapour S; Hosseinzadeh E; Marofi F; Hassanzadeh A
    J Cell Physiol; 2019 Nov; 234(11):19366-19383. PubMed ID: 31020647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic modifications of metastasis suppressor genes in colon cancer metastasis.
    Li Q; Chen H
    Epigenetics; 2011 Jul; 6(7):849-52. PubMed ID: 21758003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current Understanding of Epigenetics Driven Therapeutic Strategies in Colorectal Cancer Management.
    Deka D; Scarpa M; Das A; Pathak S; Banerjee A
    Endocr Metab Immune Disord Drug Targets; 2021; 21(10):1882-1894. PubMed ID: 33605866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of gut microbiota in epigenetic regulation of colorectal Cancer.
    Zhao Y; Wang C; Goel A
    Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188490. PubMed ID: 33321173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic Modifications and Head and Neck Cancer: Implications for Tumor Progression and Resistance to Therapy.
    Castilho RM; Squarize CH; Almeida LO
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28704968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic Alteration in Colorectal Cancer: A Biomarker for Diagnostic and Therapeutic Application.
    Essa HYS; Kusaf G; Yuruker O; Kalkan R
    Glob Med Genet; 2022 Sep; 9(3):258-262. PubMed ID: 36188672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting histone methylation for colorectal cancer.
    Huang T; Lin C; Zhong LL; Zhao L; Zhang G; Lu A; Wu J; Bian Z
    Therap Adv Gastroenterol; 2017 Jan; 10(1):114-131. PubMed ID: 28286564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetics of colon cancer.
    Khare S; Verma M
    Methods Mol Biol; 2012; 863():177-85. PubMed ID: 22359293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.